Pharma Journalist -

SGS announced that it has successfully implemented advanced techniques for the collection and use of Peripheral Blood Mononuclear Cells (PBMCs) for early phase clinical trials at its…
Read More...

Key Biologics LLC and Blood Centers of America (BCA) announced an agreement to formalize their existing business relationship and to work collectively to broaden support for cell…
Read More...

United Therapeutics Corporation and MannKind Corporation announced that they have entered into a worldwide exclusive licensing and collaboration agreement for the development and…
Read More...

Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC’s investigation into possible violations of the U.S. Foreign Corrupt…
Read More...

Olon S.p.A.announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.…
Read More...

NovellusDx and Primetech announce that Primetech will provide NovellusDx' functional genomics assay "FACT – Functional Annotation for Cancer Treatment" as an exclusive dealer in Japan…
Read More...

The European Commission has granted marketing authorization for Cablivi (caplacizumab) for the treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic…
Read More...

Evox Therapeutics Ltd announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the financing with significant new…
Read More...

Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Jivi (BAY94-9027, antihemophilic factor PEGylated-aucl) for the routine prophylactic treatment of…
Read More...

Tetraphase Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval of XERAVA (eravacycline) for the treatment of complicated intra-abdominal…
Read More...